Location History:
- Louisiana, LA (US) (2012)
- West Monroe, LA (US) (2011 - 2021)
Company Filing History:
4 out of 6 
2 out of 3 
1 out of 2 Years Active: 2011-2021
Title: Khalid A El Sayed: A Trailblazing Inventor in Neuroprotection and Cancer Treatment
Introduction:
Khalid A El Sayed, hailing from West Monroe, LA (US), is a brilliant inventor and researcher who has made significant contributions in the fields of neuroprotection and cancer treatment. With an impressive portfolio of 10 patents, he has revolutionized the medical industry with his innovative methods. Let us delve into his noteworthy patents and explore some of the companies he has been associated with in his illustrious career.
Oleocanthal Isolation and Cancer Treatment:
One of Khalid A El Sayed's latest patents revolves around a groundbreaking method for isolating S (-)-Oleocanthal from olive oil. This compound has shown remarkable potential in cancer treatment. The patent details the process of mixing water with olive oil and subsequently removing an aqueous fraction to obtain reduced S (-)-Oleocanthal containing olive oil. By filtering the aqueous fraction, he successfully creates aqueous S (-)-Oleocanthal. This innovation has paved the way for the development of novel cancer therapies, promising hope in the fight against this debilitating disease.
Neuronal Circuit-Dependent Neuroprotection by Interaction between Nicotinic Receptors:
Another remarkable patent by Khalid A El Sayed focuses on inhibiting excitotoxicity through the activation of α4β2 nicotinic acetylcholine receptors (nAChRs). By indirectly activating synaptic AMPA and NMDA receptors, the patent proposes a method to combat neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease, AIDS-related dementia, and the delayed effects of stroke. It also highlights the potential of inhibitors of α7 nACHRs, such as macrocyclic diterpenoids and methyllycaconitine (MLA), in treating diseases associated with neuronal impairment, such as glaucoma and epilepsy.
Professional Affiliations and Collaborators:
Khalid A El Sayed has made significant strides within the scientific community and has been associated with esteemed organizations throughout his career. His work has been carried out in collaboration with notable colleagues, including Peter Andrew Ferchmin and Vesna Ana Eterovic De Ferchmin. Together, they have contributed to advancements in neuroprotection and neurodegenerative disease research.
Conclusion:
Khalid A El Sayed's dedication to innovation and his relentless pursuit to improve human health through groundbreaking inventions make him a truly exceptional inventor. With his patents focusing on cancer treatment and neuroprotection, he has become a trailblazer in the medical industry. As we anticipate his future contributions, Khalid A El Sayed continues to inspire researchers and inventors around the world.